Connection

Swapan Ray to Humans

Back to Details
This is a "connection" page, showing publications Swapan Ray has written about Humans.
Swapan Ray
Connection Strength
1.183
Humans
  1. Regulation of autophagy as a therapeutic option in glioblastoma. Apoptosis. 2021 12; 26(11-12):574-599.
    View in: PubMed
    Score: 0.030
  2. Applications of CRISPR-Cas9 Technology to Genome Editing in Glioblastoma Multiforme. Cells. 2021 09 07; 10(9).
    View in: PubMed
    Score: 0.030
  3. Diosgenin as a Novel Alternative Therapy for Inhibition of Growth, Invasion, and Angiogenesis Abilities of Different Glioblastoma Cell Lines. Neurochem Res. 2020 Oct; 45(10):2336-2351.
    View in: PubMed
    Score: 0.027
  4. Synergism of 4HPR and SAHA increases anti-tumor actions in glioblastoma cells. Apoptosis. 2020 04; 25(3-4):217-232.
    View in: PubMed
    Score: 0.027
  5. Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis. Int J Mol Sci. 2019 Oct 11; 20(20).
    View in: PubMed
    Score: 0.026
  6. Quercetin and Sodium Butyrate Synergistically Increase Apoptosis in Rat C6 and Human T98G Glioblastoma Cells Through Inhibition of Autophagy. Neurochem Res. 2019 Jul; 44(7):1715-1725.
    View in: PubMed
    Score: 0.025
  7. Nonradioactive and Radioactive Telomerase Assays for Detecting Diminished Telomerase Activity in Cancer Cells after Treatment with Retinoid. Methods Mol Biol. 2019; 2019:257-273.
    View in: PubMed
    Score: 0.025
  8. Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma. Apoptosis. 2018 12; 23(11-12):563-575.
    View in: PubMed
    Score: 0.025
  9. miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells. PLoS One. 2016; 11(7):e0158537.
    View in: PubMed
    Score: 0.021
  10. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci. 2016 04 01; 27(3):271-81.
    View in: PubMed
    Score: 0.020
  11. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo. Apoptosis. 2016 Mar; 21(3):312-28.
    View in: PubMed
    Score: 0.020
  12. Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease. J Alzheimers Dis. 2016; 50(2):335-52.
    View in: PubMed
    Score: 0.020
  13. Synergistic anti-tumor actions of luteolin and silibinin prevented cell migration and invasion and induced apoptosis in glioblastoma SNB19 cells and glioblastoma stem cells. Brain Res. 2015 Dec 10; 1629:85-93.
    View in: PubMed
    Score: 0.020
  14. Carbon Nanomaterials for Drug Delivery and Cancer Therapy. J Nanosci Nanotechnol. 2015 Aug; 15(8):5501-11.
    View in: PubMed
    Score: 0.019
  15. Direct transfection of miR-137 mimics is more effective than DNA demethylation of miR-137 promoter to augment anti-tumor mechanisms of delphinidin in human glioblastoma U87MG and LN18 cells. Gene. 2015 Nov 15; 573(1):141-52.
    View in: PubMed
    Score: 0.019
  16. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull. 2014 Oct; 109:22-31.
    View in: PubMed
    Score: 0.018
  17. Combination of LC3 shRNA plasmid transfection and genistein treatment inhibited autophagy and increased apoptosis in malignant neuroblastoma in cell culture and animal models. PLoS One. 2013; 8(10):e78958.
    View in: PubMed
    Score: 0.017
  18. N-Myc knockdown and apigenin treatment controlled growth of malignant neuroblastoma cells having N-Myc amplification. Gene. 2013 Oct 15; 529(1):27-36.
    View in: PubMed
    Score: 0.017
  19. miR-138 overexpression is more powerful than hTERT knockdown to potentiate apigenin for apoptosis in neuroblastoma in vitro and in vivo. Exp Cell Res. 2013 Jun 10; 319(10):1575-85.
    View in: PubMed
    Score: 0.017
  20. Sequential hTERT knockdown and apigenin treatment inhibited invasion and proliferation and induced apoptosis in human malignant neuroblastoma SK-N-DZ and SK-N-BE2 cells. J Mol Neurosci. 2013 Sep; 51(1):187-98.
    View in: PubMed
    Score: 0.016
  21. Photofrin based photodynamic therapy and miR-99a transfection inhibited FGFR3 and PI3K/Akt signaling mechanisms to control growth of human glioblastoma In vitro and in vivo. PLoS One. 2013; 8(2):e55652.
    View in: PubMed
    Score: 0.016
  22. KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells. Mol Oncol. 2013 Jun; 7(3):464-74.
    View in: PubMed
    Score: 0.016
  23. Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-DZ cells. Neurochem Res. 2013 Feb; 38(2):420-32.
    View in: PubMed
    Score: 0.016
  24. Synergistic anti-cancer mechanisms of curcumin and paclitaxel for growth inhibition of human brain tumor stem cells and LN18 and U138MG cells. Neurochem Int. 2012 Dec; 61(7):1102-13.
    View in: PubMed
    Score: 0.016
  25. Survivin knockdown increased anti-cancer effects of (-)-epigallocatechin-3-gallate in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Exp Cell Res. 2012 Aug 01; 318(13):1597-610.
    View in: PubMed
    Score: 0.015
  26. Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells. Brain Res. 2012 May 15; 1454:1-13.
    View in: PubMed
    Score: 0.015
  27. Synergistic efficacy of a novel combination therapy controls growth of Bcl-x(L) bountiful neuroblastoma cells by increasing differentiation and apoptosis. Cancer Biol Ther. 2011 Nov 01; 12(9):846-54.
    View in: PubMed
    Score: 0.015
  28. Valproic acid induced differentiation and potentiated efficacy of taxol and nanotaxol for controlling growth of human glioblastoma LN18 and T98G cells. Neurochem Res. 2011 Dec; 36(12):2292-305.
    View in: PubMed
    Score: 0.015
  29. Combination of N-(4-hydroxyphenyl) retinamide and apigenin suppressed starvation-induced autophagy and promoted apoptosis in malignant neuroblastoma cells. Neurosci Lett. 2011 Sep 08; 502(1):24-9.
    View in: PubMed
    Score: 0.015
  30. Molecular mechanisms of anti-cancer action of garlic compounds in neuroblastoma. Anticancer Agents Med Chem. 2011 May 01; 11(4):398-407.
    View in: PubMed
    Score: 0.014
  31. SU5416 and EGCG work synergistically and inhibit angiogenic and survival factors and induce cell cycle arrest to promote apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-BE2 cells. Neurochem Res. 2011 Aug; 36(8):1383-96.
    View in: PubMed
    Score: 0.014
  32. Inhibition of cysteine proteases in acute and chronic spinal cord injury. Neurotherapeutics. 2011 Apr; 8(2):180-6.
    View in: PubMed
    Score: 0.014
  33. Molecular alterations in glioblastoma: potential targets for immunotherapy. Prog Mol Biol Transl Sci. 2011; 98:187-234.
    View in: PubMed
    Score: 0.014
  34. Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo. Neuro Oncol. 2010 Nov; 12(11):1088-101.
    View in: PubMed
    Score: 0.014
  35. Knockdown of hTERT and concurrent treatment with interferon-gamma inhibited proliferation and invasion of human glioblastoma cell lines. Int J Biochem Cell Biol. 2010 Jul; 42(7):1164-73.
    View in: PubMed
    Score: 0.013
  36. Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL-2 knockdown in human malignant neuroblastoma SK-N-DZ cells. J Neurosci Res. 2010 Mar; 88(4):877-86.
    View in: PubMed
    Score: 0.013
  37. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer. 2010 Jan 01; 116(1):164-76.
    View in: PubMed
    Score: 0.013
  38. Combination of hTERT knockdown and IFN-gamma treatment inhibited angiogenesis and tumor progression in glioblastoma. Clin Cancer Res. 2009 Dec 01; 15(23):7186-95.
    View in: PubMed
    Score: 0.013
  39. Combination of taxol and Bcl-2 siRNA induces apoptosis in human glioblastoma cells and inhibits invasion, angiogenesis and tumour growth. J Cell Mol Med. 2009 Oct; 13(10):4205-18.
    View in: PubMed
    Score: 0.013
  40. Synergistic efficacy of sorafenib and genistein in growth inhibition by down regulating angiogenic and survival factors and increasing apoptosis through upregulation of p53 and p21 in malignant neuroblastoma cells having N-Myc amplification or non-amplification. Invest New Drugs. 2010 Dec; 28(6):812-24.
    View in: PubMed
    Score: 0.013
  41. Bcl-2 inhibitor and apigenin worked synergistically in human malignant neuroblastoma cell lines and increased apoptosis with activation of extrinsic and intrinsic pathways. Biochem Biophys Res Commun. 2009 Oct 30; 388(4):705-10.
    View in: PubMed
    Score: 0.013
  42. N-Myc down regulation induced differentiation, early cell cycle exit, and apoptosis in human malignant neuroblastoma cells having wild type or mutant p53. Biochem Pharmacol. 2009 Nov 01; 78(9):1105-14.
    View in: PubMed
    Score: 0.013
  43. Bcl-2 inhibitor HA14-1 and genistein together adeptly down regulated survival factors and activated cysteine proteases for apoptosis in human malignant neuroblastoma SK-N-BE2 and SH-SY5Y cells. Brain Res. 2009 Aug 04; 1283:155-66.
    View in: PubMed
    Score: 0.013
  44. Retinoids induce differentiation and downregulate telomerase activity and N-Myc to increase sensitivity to flavonoids for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Int J Oncol. 2009 Mar; 34(3):757-65.
    View in: PubMed
    Score: 0.012
  45. Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis. Brain Res. 2008 Nov 06; 1239:216-25.
    View in: PubMed
    Score: 0.012
  46. N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells. Brain Res. 2008 Aug 28; 1227:207-15.
    View in: PubMed
    Score: 0.012
  47. Proteases and phospholipases in CNS disorders. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):225-6.
    View in: PubMed
    Score: 0.012
  48. New insights into the roles of endolysosomal cathepsins in the pathogenesis of Alzheimer's disease: cathepsin inhibitors as potential therapeutics. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):270-7.
    View in: PubMed
    Score: 0.012
  49. Modulatory effects of acetazolomide and dexamethasone on temozolomide-mediated apoptosis in human glioblastoma T98G and U87MG cells. Cancer Invest. 2008 May; 26(4):352-8.
    View in: PubMed
    Score: 0.012
  50. Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells. Neurochem Res. 2009 Jan; 34(1):87-101.
    View in: PubMed
    Score: 0.012
  51. Bcl-2 siRNA augments taxol mediated apoptotic death in human glioblastoma U138MG and U251MG cells. Neurochem Res. 2009 Jan; 34(1):66-78.
    View in: PubMed
    Score: 0.012
  52. N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-gamma sensitivity for apoptosis in human glioblastoma cells. Cancer Lett. 2008 Mar 08; 261(1):26-36.
    View in: PubMed
    Score: 0.012
  53. Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer. 2008 Feb 01; 112(3):596-607.
    View in: PubMed
    Score: 0.012
  54. Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neurooncol. 2008 Mar; 87(1):9-22.
    View in: PubMed
    Score: 0.011
  55. Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (PTEN-proficient) and U87MG (PTEN-deficient) cells. Cancer Chemother Pharmacol. 2008 Aug; 62(3):407-16.
    View in: PubMed
    Score: 0.011
  56. Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer. 2007 Sep 01; 110(5):1083-95.
    View in: PubMed
    Score: 0.011
  57. Combination of all-trans retinoic acid and taxol regressed glioblastoma T98G xenografts in nude mice. Apoptosis. 2007 Nov; 12(11):2077-87.
    View in: PubMed
    Score: 0.011
  58. Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma. Neurochem Res. 2007 Dec; 32(12):2203-9.
    View in: PubMed
    Score: 0.011
  59. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis. Neurochem Res. 2007 Dec; 32(12):2194-202.
    View in: PubMed
    Score: 0.011
  60. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells. Neurochem Res. 2007 Dec; 32(12):2094-102.
    View in: PubMed
    Score: 0.011
  61. Curcumin suppressed anti-apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells. Neurochem Res. 2007 Dec; 32(12):2103-13.
    View in: PubMed
    Score: 0.011
  62. Garlic compounds induced calpain and intrinsic caspase cascade for apoptosis in human malignant neuroblastoma SH-SY5Y cells. Apoptosis. 2007 Apr; 12(4):671-84.
    View in: PubMed
    Score: 0.011
  63. 5-Aminolevulinic acid-based photodynamic therapy suppressed survival factors and activated proteases for apoptosis in human glioblastoma U87MG cells. Neurosci Lett. 2007 Mar 30; 415(3):242-7.
    View in: PubMed
    Score: 0.011
  64. Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer. 2006 Dec 01; 119(11):2575-85.
    View in: PubMed
    Score: 0.011
  65. Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells. Cancer Immunol Immunother. 2007 May; 56(5):615-25.
    View in: PubMed
    Score: 0.010
  66. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci Lett. 2006 Oct 16; 407(1):53-8.
    View in: PubMed
    Score: 0.010
  67. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res. 2005 Aug 15; 81(4):551-62.
    View in: PubMed
    Score: 0.010
  68. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer. 2004 Dec 08; 3(1):36.
    View in: PubMed
    Score: 0.009
  69. Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord. 2003 Jun; 2(3):173-89.
    View in: PubMed
    Score: 0.008
  70. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev. 2003 May; 42(2):169-85.
    View in: PubMed
    Score: 0.008
  71. Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res. 2002 Jul 15; 69(2):197-206.
    View in: PubMed
    Score: 0.008
  72. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1. Autophagy. 2021 Jan; 17(1):1-382.
    View in: PubMed
    Score: 0.007
  73. Sphingosine Toxicity in EAE and MS: Evidence for Ceramide Generation via Serine-Palmitoyltransferase Activation. Neurochem Res. 2017 Oct; 42(10):2755-2768.
    View in: PubMed
    Score: 0.005
  74. Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
    View in: PubMed
    Score: 0.005
  75. Neuron specific enolase: a promising therapeutic target in acute spinal cord injury. Metab Brain Dis. 2016 06; 31(3):487-95.
    View in: PubMed
    Score: 0.005
  76. Sequestering survivin to functionalized nanoparticles: a strategy to enhance apoptosis in cancer cells. Biomater Sci. 2016 Apr; 4(4):614-26.
    View in: PubMed
    Score: 0.005
  77. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12(1):1-222.
    View in: PubMed
    Score: 0.005
  78. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Semin Cancer Biol. 2015 Dec; 35 Suppl:S276-S304.
    View in: PubMed
    Score: 0.005
  79. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol. 2015 Dec; 35 Suppl:S78-S103.
    View in: PubMed
    Score: 0.005
  80. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014 Jan 15; 22(2):673-83.
    View in: PubMed
    Score: 0.004
  81. Multi-targeted DATS prevents tumor progression and promotes apoptosis in ectopic glioblastoma xenografts in SCID mice via HDAC inhibition. J Neurooncol. 2013 Aug; 114(1):43-50.
    View in: PubMed
    Score: 0.004
  82. Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metab Brain Dis. 2013 Sep; 28(3):355-66.
    View in: PubMed
    Score: 0.004
  83. Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res. 2013 May; 38(5):895-905.
    View in: PubMed
    Score: 0.004
  84. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy. 2012 Apr; 8(4):445-544.
    View in: PubMed
    Score: 0.004
  85. Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review. J Neurosci Res. 2012 May; 90(5):913-24.
    View in: PubMed
    Score: 0.004
  86. Drug resistance in glioblastoma: a mini review. Neurochem Res. 2012 Jun; 37(6):1192-200.
    View in: PubMed
    Score: 0.004
  87. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012 Jan 04; 87(1):10-20.
    View in: PubMed
    Score: 0.004
  88. Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies. J Neurochem. 2011 Aug; 118(3):326-38.
    View in: PubMed
    Score: 0.004
  89. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res. 2009 Sep; 47(2):134-142.
    View in: PubMed
    Score: 0.003
  90. Involvement of calpain in the process of Jurkat T cell chemotaxis. J Neurosci Res. 2009 Feb 15; 87(3):626-35.
    View in: PubMed
    Score: 0.003
  91. Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis. Vitam Horm. 2009; 81:487-504.
    View in: PubMed
    Score: 0.003
  92. Extranigral neurodegeneration in Parkinson's disease. Ann N Y Acad Sci. 2008 Oct; 1139:331-6.
    View in: PubMed
    Score: 0.003
  93. Calpain as a potential therapeutic target in Parkinson's disease. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):305-12.
    View in: PubMed
    Score: 0.003
  94. Activation of calpain and caspase pathways in demyelination and neurodegeneration in animal model of multiple sclerosis. CNS Neurol Disord Drug Targets. 2008 Jun; 7(3):313-20.
    View in: PubMed
    Score: 0.003
  95. Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. J Neuroimmunol. 2007 Oct; 190(1-2):139-45.
    View in: PubMed
    Score: 0.003
  96. Calpain activation in apoptosis of motoneurons in cell culture models of experimental parkinsonism. Ann N Y Acad Sci. 2006 Aug; 1074:349-56.
    View in: PubMed
    Score: 0.003
  97. Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. Glia. 2005 Apr 15; 50(2):160-7.
    View in: PubMed
    Score: 0.002
  98. Estrogen as a multi-active neuroprotective agent in traumatic injuries. Neurochem Res. 2004 Nov; 29(11):2007-14.
    View in: PubMed
    Score: 0.002
  99. Estrogen as a neuroprotective agent in the treatment of spinal cord injury. Ann N Y Acad Sci. 2003 May; 993:125-33; discussion 159-60.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.